文献速递肾血管病与高血压遗传性与小管间质肾病

心脏局部多囊蛋白2参与利钠肽信号通路与高血压

Cardiac Localized Polycystin-2 in the Natriuretic Peptide Signaling Pathway and Hypertension.
PubMed 文献 · J Am Soc Nephrol · 2024-09-20

本研究探讨心脏局部多囊蛋白2在利钠肽信号通路中的作用及其与高血压的关系。通过心肌细胞特异性多囊蛋白2敲除小鼠模型及人iPSC衍生心肌细胞实验,发现多囊蛋白2缺失导致昼夜高血压,且利钠肽产生相关基因转录下降,人iPSC心肌细胞无法产生ANP,重新表达多囊蛋白2可恢复ANP产生。结论提示利钠肽产生需要心脏局部多囊蛋白2,该通路缺失可能促进常染色体显性多囊肾病相关高血压的发生。

要点

  • 心肌细胞特异性多囊蛋白2敲除小鼠出现昼夜高血压。
  • 多囊蛋白2缺失导致利钠肽合成通路相关基因转录下降。
  • 人iPSC心肌细胞敲除PKD2后无法产生ANP,重新表达多囊蛋白2可恢复。

核心结论

  • 利钠肽产生需要心脏局部多囊蛋白2,该通路缺失可能促进常染色体显性多囊肾病相关高血压的发生。

研究设计与样本

  • 研究采用心肌细胞特异性多囊蛋白2敲除小鼠(cPC2-KO)与Cre对照小鼠,进行遥测、超声心动图和左心室组织利钠肽通路分子分析,并在离体小鼠心脏、CRISPR/Cas9敲除PKD2的人iPSC衍生心肌细胞及体外细胞系中进行验证。

主要发现

  • cPC2-KO小鼠表现出昼夜高血压。
  • cPC2-KO小鼠与Cre小鼠的循环ANP和BNP水平无差异。
  • cPC2-KO小鼠中嗜铬粒蛋白B、PCSK6、NPR1和NFAT基因转录下降。
  • 敲除PC2的人iPSC衍生心肌细胞无法产生ANP。
  • 在成肌细胞系中重新表达多囊蛋白2可恢复ANP产生,而致病性多囊蛋白2形式不能恢复。

临床怎么用

  • 对于常染色体显性多囊肾病患者,应关注心脏局部多囊蛋白2-利钠肽通路障碍可能参与高血压发生,尤其在肾功能尚未下降的早期阶段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Cardiac localized polycystin facilitates natriuretic peptide signaling pathways. Hypertension associated with autosomal dominant polycystic kidney disease may arise from impaired cardiac natriuretic peptide signaling. BACKGROUND: Hypertension is seen in 70% of patients with autosomal dominant polycystic kidney disease by age of 30 years before decline in kidney function. However, cardiac origins of hypertension, such as the natriuretic peptide signaling pathway, have not been fully investigated. We hypothesized that cardiomyocyte localized polycystin proteins contribute to production of natriuretic peptides, and loss of this pathway would contribute to hypertension. METHODS: Telemetry, echocardiography, and a molecular analysis of the natriuretic peptide pathway from left ventricular tissue of cardiomyocyte specific knockout models of polycystin-2 (cPC2-KO) mice and Cre control littermates were conducted. Complementary studies were conducted in ex vivo murine hearts, engineered heart tissue with human iPSCs driven into cardiomyocytes with CRISPR/Cas9 knockout of PKD2 and in in vitro cell lines. RESULTS: cPC2-KO mice demonstrated diurnal hypertension. Circulating atrial natriuretic peptide (ANP) and brain natriuretic peptide were unchanged between cPC2-KO and Cre mice. Analysis of the pathways involved in production, maturation, and activity of natriuretic peptides identified decreased transcription of chromogranin B, PCSK6, NPR1, and NFAT genes in cPC2-KOs. Human iPSC-derived cardiomyocytes with PC2-KO failed to produce ANP. Re-expression of polycystin-2 in a myoblast cell line, but not pathogenic forms of polycystin-2, restored ANP production. CONCLUSIONS: Natriuretic peptide production required cardiac localized polycystin-2, and loss of this pathway may contribute to the development of hypertension in autosomal dominant polycystic kidney disease. PODCAST: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2024_10_08_ASN0000000000000490.mp3

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Márquez-Nogueras KM, Elliott B, Thuo P, et al. Cardiac Localized Polycystin-2 in the Natriuretic Peptide Signaling Pathway and Hypertension. J Am Soc Nephrol. 2024. PMID: 39302726. doi:10.1681/ASN.0000000000000490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。